CLINICAL TRIALS PROFILE FOR BRIMONIDINE TARTRATE
✉ Email this page to a colleague
All Clinical Trials for brimonidine tartrate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00061529 ↗ | A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension | Completed | Alcon Research | Phase 3 | 2003-01-01 | The primary objective of this study is to compare the safety and efficacy of Brimonidine Tartrate Ophthalmic Solution, 0.15% in patients with open-angle glaucoma or ocular hypertension. |
NCT00121147 ↗ | Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan | Completed | Alcon Research | N/A | 2003-09-01 | The purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan. |
NCT00121147 ↗ | Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan | Completed | Hermann Eye Center | N/A | 2003-09-01 | The purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for brimonidine tartrate
Condition Name
Clinical Trial Locations for brimonidine tartrate
Trials by Country
Clinical Trial Progress for brimonidine tartrate
Clinical Trial Phase
Clinical Trial Sponsors for brimonidine tartrate
Sponsor Name